Infectious Disease

Roche (OTCQX:RHHBY) announces launch of the first infectious disease tests on the cobas 5800 System, a new molecular laboratory instrument, in countries accepting the CE mark. These include cobas HIV-1, cobas HBV, cobas HCV, cobas HIV-1/HIV-2 Qualitative, and the cobas omni Utility Channel kit. These launches expand the Roche Molecular...

Excess deaths across South Africa have not risen sharply despite a huge wave of Covid-19 omicron infections, according to new data released on Wednesday evening. The figures further raise hopes that the highly mutated omicron variant may be milder than other forms of the virus – although experts warned that this may not help the NHS.

As the coronavirus pandemic continues, holiday plans for many are meeting increased concern around the developing Omicron variant and a recent increase in case numbers in large portions of the United States. Experts agree that vaccinations (particularly booster shots) are effective against the Omicron variant, but the country's vaccination rate...

The Middle East has seen an 888% increase in the number of infectious disease trials taking place over the past decade, the largest increase for any region worldwide. The region now ranks in first for the total number of trials taking place, compared to its sixth-placed ranking in 2010. These...

On December 7, 2021, the Government of Ontario extended the COVID-19 Worker Income Protection Benefit and the temporary amendments to the Employment Standards Act, 2000, which provided for the infectious disease emergency leave (IDEL) provisions. These initiatives were set to expire at the end of December 2021. The COVIDIDE-19 Worker Income Protection Benefit program and the IDEL will now extend until July 31, 2022, and July 30, 2022, respectively.

Health experts have detected a trend that a particular COVID-19 symptom is being more commonly reported in limited Omicron research thus far. 9 kinds of COVID-19 symptoms are still very much possible for anyone infected by the Omicron variant, but fatigue seems to be the most common so far. Early...

Peter Bergen interviewed infectious disease expert and professor at the University of Minnesota, Michael Osterholm, who predicted in April 2020 that 800,000 Americans would die of Covid-19 within 18 months. Now, with over 790,000 Americans dead, Osterholm talks to Bergen about what lies ahead for the country and the world as we get close to two years battling pandemic.

PLEASANTON, Calif., Dec. 15, 2021 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the first infectious disease tests on the cobas® 5800 System, a new molecular laboratory instrument, in countries accepting the CE mark. These include cobas® HIV-1, cobas® HBV, cobas® HCV, cobas® HIV-1/HIV-2 Qualitative, and the cobas omni Utility Channel kit. These launches expand the Roche Molecular portfolio offering by providing standardised performance and efficiencies across low, medium and high volume molecular laboratory testing needs.

Peter Bergen is CNN's national security analyst, a vice president at New America and a professor of practice at Arizona State University. He is the senior editor of the Coronavirus Daily Brief and author of the new book "The Rise and Fall of Osama bin Laden." The opinions expressed here are his own. Read more opinion at CNN.

The COVID-19 pandemic has turned the spotlight on infectious disease doctors. They've acted as public health messengers, conveying the importance of interventions such as masking, social distancing, and vaccination, and answering questions about viral evolution and transmission. They've established infection protocols to keep medical teams afloat during the public health emergency.

WASHINGTON (TND) — On Thursday, the Centers for Disease Control and Prevention began urging 16 and 17-year-olds to get a booster dose of Pfizer's COVID-19 vaccine once they're six months past their last shot and recommendations for a fourth booster shot could be coming down the line. This has...

The Omicron variant of the coronavirus made a splash in headlines just a few weeks ago, and now the previously unknown COVID variant has caused travel restrictions and concern. Scientists are rushing to understand what exactly this new variant has in store for us. Early data has hinted that the...

A mother said she felt hopeless as she watched her daughter battle an illness called multi-system inflammatory syndrome (MIS-C). Children can develop it after contracting COVID-19. She said her little girl spent nearly two weeks in OU Children's Hospital while suffering from MIS-C. She was recently released but has a...

Early findings have suggested that the new omicron variant may cause milder disease than other coronavirus strains — potentially encouraging news that experts in the Bay Area are still greeting with caution. Even if omicron causes less severe infection, the highly mutated strain is already showing signs of even...